The Porphyromonas Denticanis-Gulae-Salivosa Bacterin is approved for the vaccination of healthy dogs as an aid in preventing periodontitis, as demonstrated by a reduction in bone changes (osteolysis/osteosclerosis).
Advantages:
Porphyromonas Denticanis-Gulae-Salivosa Bacterin is the first and only vaccine to aid in the prevention of canine periodontitis which affects 85% of dogs over 3 years of age.1 This product is an important new adjunct to professional dental cleaning, periodontal therapy and owner-administrated dental care routines.
The Porphyromonas Vaccine is part of a complete canine wellness program that encourages annual visits.
Safety of the vaccine was evaluated in laboratory studies and a field safety study.
Key Features:
Inactivated P. denticanis, P. gulae and P. salivosa bacterin (liquid form)
Adjuvant to enhance immune response
Primary vaccination—two doses, three week apart
Twenty-five 1 mL doses per carton
Adminster 1 mL subcutaneously
Directions:
General Directions: Vaccination of healthy dogs is recommended. Shake well. Aspetically administer 1 mL subcutaneously.
Primary Vaccination: Healthy dogs should receive 2 doses administered 3 weeks apart. Revaccination: Duration of immunity for this product has not been determined; six and twelve month intervals are being evaluated.